But experts are now concerning the risk is increased for men who do one specific thing.
Dodging regular prostate can.cer screening appointments grows the risk of d3ath by 45 percent, health experts are now concerning.
If screenings were shown on a national scale, especially ones that use a prostate-specific antigen (PSA) in the blood, it could catch prostate can.cer earlier and give men access to the treatment.
Collating information from seven countries across Europe for the past two decades in the world’s largest prostate can.cer screening study, the early chance would lead to a better chance of being cured – and prevent costly medical treatments.
The information consistently reports PSA screenings can weaken the risk of d3ath from prostate can.cer by 20 percent.
The research spanning the past 20 years shows a connection between the decrease in people attending prostate screening consultations and men’s risk of dy:ing from it.
It reveals a ‘stark contrast’ in the dire consequences of avoiding screenings.
Around one in six were deemed non-attenders, having missed every single appointment.
This put them at a 45 percent higher risk of dy:ing from prostate can.cer compared to those who showed up to their appointments.
Meanwhile, those who attended had a 23 percent lower risk of dy:ing from prostate can.cer and non-attenders had a 39 percent higher risk.
It may be that men who opted not to attend a screening appointment are care avoiders – meaning they’re less likely to employ in healthy behaviors and preventative care in general.”
She added: “This is the opposite behavior of people who are perhaps more health-conscious and are more likely to attend a screening appointment.”
“This will help us to create population-based prostate can.cer screening programmes that support higher rates of informed participation. Solving attendance rates in this way could be a big reason in the long-term success of a national prostate screening programme,” she said.
